Shares of Inovio Pharmaceuticals (INO) rose by a staggering 43.64% in 30 days from $6.37 to $9.15 at 20:33 EST on Thursday, after four consecutive sessions in a row of gains. NASDAQ Composite (INO) is jumping 0.78% to $14,020.33, following the last session’s downward trend,
Inovio Pharmaceuticals’s last close was $10.03, 70.32% under its 52-week high of $33.79.
Today’s last reported volume for Inovio Pharmaceuticals is 7627347 which is 11.49% below its average volume of 8617379.
Inovio Pharmaceuticals’s Sales
Inovio Pharmaceuticals’s sales growth is 274.5% for the current quarter and 5133.1% for the next. The company’s growth estimates for the ongoing quarter is 69.9% and a drop 300% for the next.
Inovio Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth grew by 1896.7%, now sitting on 7.41M for the twelve trailing months.
Inovio Pharmaceuticals’s last week, last month’s, and last quarter’s current volatility was 3.05%, 0.82%, and 3.29%, respectively.
Inovio Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.94% (last week), 2.90% (last month), and 3.29% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Inovio Pharmaceuticals’s stock is considered to be oversold (<=20).
Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value
Inovio Pharmaceuticals’s stock is valued at $9.15 at 20:33 EST, way below its 52-week high of $33.79 and way above its 52-week low of $5.81.
Inovio Pharmaceuticals’s Moving Average
Inovio Pharmaceuticals’s worth is way above its 50-day moving average of $7.29 and under its 200-day moving average of $9.79.
More news about Inovio Pharmaceuticals (INO).